Huyabio signs clinical collaboration agreement for phase III melanoma trial of HBI-8000 with Opdivo March 31, 2021
Pyxis Oncology enters worldwide agreement with Pfizer to develop and commercialize novel ADCs March 22, 2021
Exelixis collaborates with Merck KGaA and Pfizer to evaluate XL-092 plus avelumab in UC March 19, 2021
T-Cure enters clinical research agreement to support phase I study of KK-LC-1 TCR therapy March 18, 2021
Xenon collaborates with Mount Sinai on phase II study of XEN-1101 for MDD and anhedonia March 9, 2021
ESSA Pharma and Astellas collaborate to investigate EPI-7386 plus enzalutamide in mCRPC Feb. 26, 2021
RSS